Navigation Links
New Pharmaxis Board Appointment
Date:6/23/2008

SYDNEY, Australia, June 23 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced the appointment of senior Australian pharmaceutical executive Will Delaat to its board of directors.

Mr Delaat has 35 years experience in the global pharmaceutical industry, most recently as the managing director of the Australian subsidiary of Merck & Co., a position he held from 1997 until his recent retirement.

During his career Mr Delaat has held executive positions in both Europe and Australia for Merck and AstraZeneca. Mr Delaat is experienced in sales and marketing and has been responsible for international product launches and commercialisation of respiratory products.

Mr Delaat also serves the pharmaceutical industry in important representative roles. He is chairman of the Australian pharmaceutical industry's peak body, Medicines Australia, and is chairman of the Pharmaceuticals Industry Council.

''Will Delaat is one of Australia's pharmaceutical industry leaders'' said Pharmaxis Chairman, Denis Hanley. ''The Pharmaxis board will benefit from his invaluable skills and experience.''

In accepting the board director position Mr Delaat said: ''Pharmaxis holds enormous promise and I look forward to being part of its effort to bring innovative medicines to patients world-wide."

For information on all Pharmaxis Board members, go to http://tinyurl.com/3s4g2n .

Forward-Looking Statements

The statements contained in this media release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this media release include statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for Aridol and/or Bronchitol. All forward-looking statements incl
'/>"/>

SOURCE Pharmaxis Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Pharmaxis Aridol Authorised for Sale in Germany
2. Pharmaxis First Steps into China
3. Pharmaxis to Apply to Market Bronchitol in Australia
4. Pharmaxis Investor Conference Call
5. Pharmaxis Aridol Gains First Asian Approval
6. Pharmaxis Appoints Portuguese Distributor for Aridol
7. Pharmaxis Closes Share Purchase Plan
8. Pharmaxis Announces Placement of $50 Million and Share Purchase Plan
9. Phase III Trial Finds Pharmaxis Bronchitol Effective
10. Corgenix Expands Scientific Advisory Board
11. Spring Point Project Names New Members to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014 TaiGen Biotechnology Company, Limited ("TaiGen") ... with R-Pharm, a leading Russian pharmaceutical company, to develop ... Russian Federation , Turkey ... (CIS). Nemonoxacin is a novel antibiotic for the treatment of ...
(Date:1/14/2014)... Jan. 14, 2014 As pet owners drew up their lists ... them wrote: "Take better care of my furry companion." Nowadays there ... and top-brand carrying cases to take the little canine or feline ... feel compelled to buy some pricey toys at the pet store. ...
(Date:1/14/2014)... In recent years, growing suspicion about the pharmaceutical ... and promotion has led to unprecedented levels of public ... about the insidious impact of commercialization of research, has ... the world’s biggest pharmas for illegal marketing activities, allegations ...
(Date:1/14/2014)... 2014 Kerr Corporation, a leading manufacturer of ... how-to information about dual arch impressions on its dental blog. ... Impressions,” the blog entry serves up a list of tips ... step-by-step demonstration by Dr. David Little as he crafts a ...
Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3
... This release is available in German . ... from the physics department at the TUM discovered an entirely ... grid of magnetic eddies. Together with the team of Professor ... properties of these eddies, so-called skyrmions, named after the British ...
... Calif., Feb. 21, 2012 Onyx Pharmaceuticals, Inc. (Nasdaq: ... conferences in February and March. 2012 Citi Global ... Healthcare Conference on Monday, February 27, 2012 at 10:00 a.m. Eastern ... Company 32nd Annual Health Care Conference Onyx will present at ...
... 21, 2012  Wake Forest Baptist Medical Center has ... a new state-of-the-art, world-class 242,000 square foot biotechnology ... growth of Wake Forest Baptist,s many renowned research ... companies generated by researchers, discoveries and space for ...
Cached Biology Technology:Saving data in vortex structures 2Onyx Pharmaceuticals to Present at Upcoming Investor Conferences 2Wake Forest Baptist Medical Center Unveils Historic World-Class Biotech Research & Innovation Center in Downtown Winston-Salem's Growing Piedmont Triad Research Park 2Wake Forest Baptist Medical Center Unveils Historic World-Class Biotech Research & Innovation Center in Downtown Winston-Salem's Growing Piedmont Triad Research Park 3Wake Forest Baptist Medical Center Unveils Historic World-Class Biotech Research & Innovation Center in Downtown Winston-Salem's Growing Piedmont Triad Research Park 4
(Date:4/23/2014)... domestic heating may contribute to early fetal death according ... Research Institute of Children,s Hospital Los Angeles and Ulaanbaatar, ... , In a paper published today in the journal ... strong statistical correlations" between seasonal ambient air pollutants and ... has one of the highest levels of air pollution ...
(Date:4/23/2014)... hungry diner ripping open a dinner roll, a fuel ... open a hydrogen molecule. Now researchers have captured a ... halves of its hydrogen feast. The view confirms previous ... catalyst work better for alternative energy uses. , This ... where the hydrogen halves end up in the structure ...
(Date:4/23/2014)... shows that male black widow spiders prefer their female ... of mate preference by male spiders. , ... Maydianne Andrade, a professor in UTSC,s Department of Biological ... wild that males overwhelmingly chose to mate with well-fed, ... tell whether a potential mate is well-fed and unmated ...
Breaking Biology News(10 mins):Pollutants from coal-burning stoves strongly associated with miscarriages in Mongolia 2Halving hydrogen 2Halving hydrogen 3Halving hydrogen 4Picky male black widow spiders prefer well-fed virgins 2
... research team has tested the utility of the short version ... disability in patients with depression, "which in the case of ... of the instrument." In Spain, more than 10% of ... is usually the first to screen an individual who feels ...
... today by ESA,s Envisat satellite, shows the vast cloud of ... Iceland, more than 1000 km away. Carried by winds ... the eruption of the Eyjafjallajoekull glacier in southwest Iceland has ... Scandinavia, with further disruption in northern Europe expected later today. ...
... This press release is available in French . ... of the 20th century, but new research shows initiatives of ... dollars as people might think. McGill University Biologist Dr. Jonathan ... most affected by them is a far more effective and ...
Cached Biology News:It takes only 5 minutes to assess disability in patients with depression 2Trying to eradicate a disease is a waste of money: researcher 2